| Inherited DOCK2 deficiency in patients with early-onset invasive infections K Dobbs, C Domínguez Conde, SY Zhang, S Parolini, M Audry, J Chou, ... New England Journal of Medicine 372 (25), 2409-2422, 2015 | 193 | 2015 |
| B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape S Pesce, G Tabellini, C Cantoni, O Patrizi, D Coltrini, F Rampinelli, J Matta, ... Oncoimmunology 4 (4), e1001224, 2015 | 183 | 2015 |
| Defective natural killer–cell cytotoxic activity in NFKB2-mutated CVID-like disease V Lougaris, G Tabellini, M Vitali, M Baronio, O Patrizi, G Tampella, ... Journal of Allergy and Clinical Immunology 135 (6), 1641-1643. e3, 2015 | 71 | 2015 |
| Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations G Tabellini, D Vairo, O Scomodon, N Tamassia, RM Ferraro, O Patrizi, ... Journal of Allergy and Clinical Immunology 140 (2), 553-564. e4, 2017 | 62 | 2017 |
| Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A … K Dobbs, G Tabellini, E Calzoni, O Patrizi, P Martinez, SC Giliani, ... Frontiers in immunology 8, 798, 2017 | 52 | 2017 |
| Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects L Lorenzi, G Tabellini, W Vermi, D Moratto, F Porta, LD Notarangelo, ... PloS one 8 (11), e80131, 2013 | 51 | 2013 |
| NFKB1 regulates human NK cell maturation and effector functions V Lougaris, O Patrizi, M Baronio, G Tabellini, G Tampella, E Damiati, ... Clinical Immunology 175, 99-108, 2017 | 46 | 2017 |
| Strengthening the AntiTumor NK cell function for the treatment of ovarian cancer M Greppi, G Tabellini, O Patrizi, S Candiani, A Decensi, S Parolini, ... International journal of molecular sciences 20 (4), 890, 2019 | 39 | 2019 |
| CTLA-4 regulates human Natural Killer cell effector functions V Lougaris, G Tabellini, M Baronio, O Patrizi, L Gazzurelli, N Mitsuiki, ... Clinical Immunology 194, 43-45, 2018 | 35 | 2018 |
| Effects of opioid therapy on human natural killer cells G Tabellini, E Borsani, M Benassi, O Patrizi, D Ricotta, L Caimi, R Lanzi, ... International immunopharmacology 18 (1), 169-174, 2014 | 30 | 2014 |
| Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis G Tabellini, M Benassi, E Marcenaro, D Coltrini, O Patrizi, D Ricotta, ... Case Reports in Oncology 7 (1), 70-78, 2014 | 18 | 2014 |
| The RAC2-PI3K axis regulates human NK cell maturation and function G Tabellini, M Baronio, O Patrizi, A Benevenuto, L Gazzurelli, A Plebani, ... Clinical immunology (Orlando, Fla.) 208, 108257, 2019 | 12 | 2019 |
| p85α is an intrinsic regulator of human natural killer cell effector functions V Lougaris, O Patrizi, M Baronio, G Tabellini, G Tampella, G Lanzi, ... Journal of Allergy and Clinical Immunology 138 (2), 605-608. e3, 2016 | 7 | 2016 |
| Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner O Patrizi, M Baronio, L Gazzurelli, S Rossi, S Rezzola, E Marcenaro, ... Clinical Immunology 237, 108974, 2022 | 5 | 2022 |
| From natural killer cell receptor discovery to characterization of natural killer cell defects in primary immunodeficiencies G Tabellini, O Patrizi, K Dobbs, V Lougaris, M Baronio, D Coltrini, ... Frontiers in Immunology 10, 1757, 2019 | 5 | 2019 |
| Natural killer cell impairment in ovarian clear cell carcinoma O Patrizi, F Rampinelli, D Coltrini, S Pesce, S Carlomagno, S Sivori, ... Journal of Leucocyte Biology 108 (4), 1425-1434, 2020 | 4 | 2020 |
| DOCK2 and a recessive immunodeficiency with early-onset invasive infections K Dobbs, CD Conde, SY Zhang, S Parolini, M Audry, J Chou, ... The New England journal of medicine 372 (25), 2409, 2015 | 4 | 2015 |
| Response to the Letter to the Editor Regarding" Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients" V Lougaris, G Tabellini, M Baronio, O Patrizi, S Parolini, A Plebani Immunology letters 200, 16-17, 2018 | | 2018 |
| Edited and Reviewed by: Megan Anne Cooper, Washington University in St. Louis, United States S Parolini, LD Notarangelo, K Dobbs, G Tabellini, E Calzoni, O Patrizi, ... Frontiers in Immunology 8 (1244), 1, 2017 | | 2017 |
| Edited by: Megan Anne Cooper, Washington University in St. Louis, United States Reviewed by Y Bryceson, E Mace, S Parolini, LD Notarangelo, K Dobbs, G Tabellini, ... Frontiers in Immunology 8 (798), 1, 2017 | | 2017 |
